Considering that synaptic density is highly correlated with cognitive performance in a larger sample of participants with AD [45], it is possible that loss of mGluR5 and SV2A are markers of disease progression that are highly related due to their locations at the synapse. The gene discussed is GRM5; the disease is Alzheimer disease.